Broccoli may be a ‘turning point’ in understanding cancer

Cancer Tutor

Oregon State University researchers have discovered that sulforaphane, a dietary compound known to help prevent prostate cancer, is one of the reasons why broccoli may be good for your health.

The finding provides more evidence for how long non-coding RNAs, which were once thought to be a type of “junk DNA” of no particular value or function, may instead play a critical role in triggering cells to become malignant and spread.

Evidence shows that lncRNAs have a major role in cell biology and development, often by controlling what genes are turned on, or “expressed” to carry out their genetic function. Scientists now believe that when these lncRNAs are dysregulated they can contribute to multiple disease processes, including cancer.

“This could be a turning point in our understanding of how cancer may be triggered and spreads,” said Emily Ho, director of the Moore Family Center for Whole Grain Foods, Nutrition and Preventive Health at OSU. The findings were published in the Journal of Nutritional Biochemistry. [1]

The lncRNAs are of special interest, researchers say, because they are so highly cell- and tissue-specific. Unlike many chemotherapeutic drugs that affect healthy cells as well as malignant ones and can cause undesired side effects, the control of lncRNAs may offer a new way to specifically prevent or slow the progression of malignant cells.

“It’s obviously of interest that this dietary compound, found at some of its highest levels in broccoli, can affect lncRNAs,” said Ho, who also is the principal investigator with the Linus Pauling Institute. “This could open the door to a whole range of new dietary strategies, foods or drugs that might play a role in cancer suppression or therapeutic control.”

In particular, this research showed that one lncRNA, called LINC01116, is upregulated in a human cell line of prostate cancer, but can be decreased by treatment with sulforaphane. The data “reinforce the idea that lncRNAs are an exciting new avenue for chemoprevention research, and chemicals derived from diet can alter their expression,” the scientists wrote in their study.

The impact of diet on lncRNA expression has been largely unknown until now, the researchers said. In this study, they identified a four-fold decrease in the ability of prostate cancer cells to form colonies when LINC01116 was disrupted.

That same lncRNA, they noted, is also overexpressed in studies of several other types of cancer, including brain, lung and colon cancer. Some other lncRNAs have been found at higher levels in breast, stomach, lung, prostate cancer and chronic lymphocytic leukemia.

“We showed that treatment with sulforaphane could normalize the levels of this lncRNA,” said Laura Beaver, a research associate in the Linus Pauling Institute and College of Public Health and Human Sciences, and lead author on the study. “This may relate to more than just cancer prevention. It would be of significant value if we could develop methods to greatly slow the progress of cancer, help keep it from becoming invasive.”

Among men, prostate cancer is the second most frequently diagnosed cancer globally, and the second leading cause of cancer-related deaths in the United States. Worth noting, the researchers said, is that an increased consumption of cruciferous vegetables such as broccoli, which are high in sulforaphane, appears to be associated with a lower risk of developing prostate cancer.

Must Read

The second most common cancer among men, worldwide, 1 in 6 will be diagnosed with prostate cancer in their lifetime.

Read time: 4 mins | 20

Need Help?

Cancer Tutor is here for you. Personalize your cancer research with a Free Cancer Tutor Account.
You will be able to favorite articles, follow authors, save notes directly on articles, download eBooks, post in our Cancer Forums, and much more.

Forum

Donate

Help keep Cancer Tutor on the cutting edge of relevant natural treatments -- and display ad-free. Your donation also helps further the research of the Independent Cancer Research Foundation, Inc. (ICRF).